Embla Medical hf.
EMBLA.CO
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.02B
Close$
Share Statistics
| Market cap | $13.02 Billion |
|---|---|
| Enterprise Value | $13.48 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.2 |
| Beta | 0.46 |
| Outstanding Shares | 429,779,412 |
Return
| Return on Equity | 10.17% |
|---|---|
| Return on Assets | 5.45% |
| Return on Invested Capital | 10.44% |
Valuation & Multiples
| P/E Ratio | 18.93 |
|---|---|
| PEG | 50.41 |
| Price to Sales | 13.83 |
| Price to Book Ratio | 13.83 |
| Enterprise Value to Revenue | 13.73 |
| Enterprise Value to EBIT | 96.05 |
| Enterprise Value to Net Income | 143 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 21, 2026
EPS Estimate
$0.36
Average shareholder expectationRevenue Estimate
$1.68 B
Average shareholder expectationNext Earnings Call
Expected Date
October 20, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$1.69 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Embla Medical hf.
4,500 employees
CEO: Sveinn Sölvason Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bra...